Dr. Lorrin Koran On Medication Treatment of OCD
Lorrin M. Koran, M.D.
Professor, Department of Psychiatry and Behavioral Sciences
Director of the Obsessive-Compulsive Disorder Clinic
Stanford University Medical Center
Dr. Koran has disclosed that he has received research grants from Forest Laboratories, Eli Lilly & Co., Pfizer Inc., and AstraZeneca, and is a member of the speakers bureaus of Forest Laboratories and Pfizer Inc.
_-The-Breakthrough-Antipsychotic-That-Could-Change-Everything.webp?t=1729528747 "KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg")
